Background The COVID-19 pandemic is having profound mental health consequences for
many people. Concerns have been expressed that, at their most extreme, these …

BackgroundMortality has been suggested to be increased in autism spectrum disorder
(ASD). AimsTo examine both all-cause and cause-specific mortality in ASD, as well as …

Importance It has remained unclear whether there are clinically meaningful differences
between antipsychotic treatments with regard to preventing relapse of schizophrenia, owing …

Background Predicted increases in suicide were not generally observed in the early months
of the COVID-19 pandemic. However, the picture may be changing and patterns might vary …

Introduction It has remained controversial if antipsychotic treatment is associated with
increased or decreased mortality among patients with schizophrenia, and if there are any …

Background: It is generally believed that long-term use of antipsychotics increases mortality
and, especially, the risk of cardiovascular death. However, there are no solid data to …

Objective: Although mortality related to psychotropic medications has received much
attention in recent years, little is known about the relationship between risk of death and …

Background Until now, sparse and contradictory results about an association between
adverse neonatal, obstetric, and maternal conditions and heightened suicide risk in …

Introduction Familial clustering of suicidal behaviour and psychopathology has been
reported in young suicide attempters. Most of these studies were predominantly carried out …

Importance Most evidence about efficacy and safety of antipsychotics in schizophrenia
spectrum disorders relies on randomized clinical trials (RCTs). However, owing to their strict …